An Interdisciplinary Approach to Address Drug Shortages

Article

Keynote SeriesPharmaceutical Technology and BioPharm International are sponsoring a Keynote Series session on strategies and innovations to reduce drug shortages and improve availability of medicines on the INTERPHEX 2016 Exhibit Hall Innovation Stage. Admission is free to any attendee with an exhibit hall pass.

Wednesday, April 27
1:30–3:15 pm
Strategies and Innovations to Reduce Drug Shortages and Improve Availability of Medicines
Aging facilities and equipment, inadequate operator training, a lack of quality control, tighter regulatory enforcement, and business decisions to eliminate unprofitable product lines contribute to ongoing shortages vital drug products. In this session, industry thought leaders will identify triggers for drug shortages, methods to avoid production line shutdowns and update facilities, and innovative industry efforts to fulfill demand for needed therapies. A Q&A session will follow the presentations.

1:30–2 pm
An Interdisciplinary Approach to Address Drug Shortages
The effects of drug shortages on patients, caregivers, hospitals, and medical professionals are often not observed or understood by the bio/pharmaceutical manufacturing segment. The implications of production and quality problems, as well as business decisions to limit or terminate production of needed but unprofitable drugs, are far-reaching. This presentation will explore alternative, innovative, and cost-effective ways to provide needed therapies to patients.

Speaker: Stephen P. Spielberg, MD, PhD, Industry Consultant, Secure Affordable Quality Supply

To register: http://www.interphex.com/pharmtech

Other presentations in this session:

2-2:30 pm
BARDA Innovation Initiatives in Medical Countermeasure Manufacturing

2:30-3 pm
Continuous Manufacturing for Rapid Process Development

View the complete Keynote Series Program

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content